Fukuda Denshi Co., Ltd.

Equities

6960

JP3806000000

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange Other stock markets 07:00:00 27/06/2024 BST			5-day change	1st Jan Change
6,840 ^JPY	+2.24%		+13.43%	-7.19%

06-18	Japanese Stocks Rebound Following Wall Street Rally	MT
06-18	Fukuda Denshi's Attributable Profit Up 8.2% in Fiscal 2024	MT

Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2025

June 17, 2024 at 08:00 am

Fukuda Denshi Co., Ltd. provided consolidated earnings guidance for the year ending March 31, 2025. For the year, the company expects net sales of JPY 135,000 million, Operating profit of JPY 23,000 million, Profit attributable to owners of parent of JPY 16,500 million or JPY 572.42 per share.

Latest news about Fukuda Denshi Co., Ltd.

Japanese Stocks Rebound Following Wall Street Rally	06-18	MT
Fukuda Denshi's Attributable Profit Up 8.2% in Fiscal 2024	06-18	MT
Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2025	06-17	CI
Fukuda Denshi Co., Ltd. Announces Year End Extra Dividend for the Year Ended March 31, 2024, Payable on June 28, 2024; Provides Extra Dividend Guidance for the End of Second Quarter and Year Ending March 31, 2025	06-17	CI
Fukuda Denshi Co., Ltd. Provides Ordinary Dividend Guidance for the Second Quarter-End and Fiscal Year Ending March 31, 2025	06-17	CI
Fukuda Denshi Co., Ltd. Announces Dividend for the Year Ending March 31, 2024, Payable on June 28, 2024	06-17	CI
Fukuda Denshi Co., Ltd Announces Notice on Shareholder Proposal	05-15	CI
Fukuda Denshi Co., Ltd. Revises Dividend Guidance for the Year Ending March 31, 2024	05-13	CI
Fukuda Denshi Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024	05-13	CI
Fukuda Denshi Co., Ltd. Announces Special Dividend for the Year Ended March 31, 2024	05-13	CI
Fukuda Denshi Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024	02-21	CI
Fukuda Denshi Co., Ltd. Provides Special Dividend Guidance for the Year Ending March 31, 2024	02-21	CI
Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	02-21	CI
Fukuda Denshi Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024	02-21	CI
Senzime Licensee Fukuda Denshi Launches Integrated Tetragraph Module in Japanese Market	02-07	CI
Tranche Update on Fukuda Denshi Co., Ltd.'s Equity Buyback Plan announced on January 31, 2024.	02-01	CI
Fukuda Denshi Co., Ltd.'s Equity Buyback announced on January 31, 2024, has closed with 1,428,700 shares, representing 4.72% for ¥11,258.16 million.	01-31	CI
Fukuda Denshi Co., Ltd. announces an Equity Buyback for 2,000,000 shares, representing 6.61% for ¥15,760 million.	01-31	CI
Fukuda Denshi Co., Ltd. authorizes a Buyback Plan.	01-30	CI
Fukuda Denshi’s Attributable Profit up 20.8% in Fiscal H1	11-20	MT
Fukuda Denshi Co., Ltd. Provides Ordinary Dividend Guidance for the Ending March 31, 2024	11-20	CI
Fukuda Denshi Co., Ltd. Announces Extra Dividend for the Second Quarter Ended September 30, 2023, Scheduled Date for Commencement of Dividend Payment of December 4, 2023 and Provides Dividend Guidance for the Ending March 31, 2024	11-20	CI
Fukuda Denshi Co., Ltd. Announces Ordinary Dividend for the Second Quarter Ended September 30, 2023, Scheduled Date for Commencement of Dividend Payment of December 4, 2023	11-20	CI
Fukuda Denshi Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	25/10/23	CI
Cross SYNC. Inc. announced that it has received ¥510 million in funding from a group of investors	29/08/23	CI

Chart Fukuda Denshi Co., Ltd.

Duration

Period

More charts

Company Profile

FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.

Sector

Advanced Medical Equipment & Technology

Calendar

30/07/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

6,840 JPY

Average target price

6,600 JPY

Spread / Average Target

-3.51%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
FUKUDA DENSHI CO., LTD.	-7.19%	1.2B
THERMO FISHER SCIENTIFIC	+3.77%	213B
DANAHER CORPORATION	+8.83%	188B
INTUITIVE SURGICAL, INC.	+31.94%	157B
BOSTON SCIENTIFIC CORPORATION	+33.19%	113B
SIEMENS HEALTHINEERS AG	+5.25%	64.85B
EDWARDS LIFESCIENCES CORPORATION	+22.41%	55.17B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+1.34%	49.1B
AGILENT TECHNOLOGIES, INC.	-5.92%	38.83B
GE HEALTHCARE TECHNOLOGIES INC.	+1.94%	35.6B

Other Advanced Medical Equipment & Technology